Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

Frankincense may help treat COVID-19, but more research is needed.

COVID-19 can cause significant hair loss.

A man had nail and hair changes months after severe Covid-19, showing long-term effects.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

A woman's hair loss improved with treatment after a COVID-19 infection.